BeiGene wins US approval to expand Tevimbra brand (BGNE:NASDAQ)

Beijing (Nasdaq:LevaThe U.S. Food and Drug Administration (FDA) has approved the cancer drug Tevimbra (tislelizumab-jsgr) in combination with chemotherapy as a first-line option for certain forms of stomach cancer, or gastric cancer, it announced on Friday.

Specifically, an anti-PD-1 monoclonal antibody will do this